Evermay Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
Evermay Wealth Management's XBI Position: Q3 2026 in Review
Evermay Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 175 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #404.
Evermay Wealth Management first reported a position in XBI in Q3 2021 and has held it in 21 quarters since. The position peaked at $50K in Q4 2021. 559 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Evermay Wealth Management held 175 shares of State Street SPDR S&P Biotech ETF worth $27.6K as of Q3 2026.
- Evermay Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Evermay Wealth Management's portfolio in Q3 2026, its #404 holding.
- Evermay Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 21 quarters since.
- Evermay Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $50K in Q4 2021.
- 559 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Evermay Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.